Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 84

    Shilpa Medicare gets 2 USFDA observations for Telangana facility

    Shilpa Medicare gets 2 USFDA observations for Telangana facility

    Medical Dialogues Bureau9 Sept 2019 11:50 AM IST
    The US Food and Drug Administration (USFDA) inspected the company's finished dosage formulation facility located at Pharmaceutical Formulations SEZ,...
    Aurobindo Pharma recalls 2352 bottles of Simvastatin tablets over labelling issue

    Aurobindo Pharma recalls 2352 bottles of Simvastatin tablets over labelling issue

    Medical Dialogues Bureau9 Sept 2019 9:45 AM IST
    The reason for the recall of lipid-lowering Simvastatin tablets is "Labeling; incorrect or missing lot and/or exp date; some bottles labelled with lot...
    AstraZeneca Imfinzi shows to increase survival in aggressive lung cancer

    AstraZeneca Imfinzi shows to increase survival in aggressive lung cancer

    Medical Dialogues Bureau9 Sept 2019 9:30 AM IST
    Imfinzi, when combined with chemotherapy, resulted in a median 13 months survival in a late-stage small cell lung cancer trial, AstraZeneca said,...
    Amgen drug AMG510 shrinks lung cancer tumours in half of patients in early-stage trial

    Amgen drug AMG510 shrinks lung cancer tumours in half of patients in early-stage trial

    Medical Dialogues Bureau9 Sept 2019 9:15 AM IST
    Patients who responded to the drug AMG510 have been treated for a median of 15 weeks, but the median duration of response has not been reached,...
    Purdue Pharma expected to file for bankruptcy post opioid talks fail

    Purdue Pharma expected to file for bankruptcy post opioid talks fail

    Medical Dialogues Bureau9 Sept 2019 9:00 AM IST
    CLEVELAND: OxyContin maker Purdue Pharma is expected to file for bankruptcy after settlement talks over the nation's deadly overdose crisis hit an...
    Novo Nordisk in race with rivals Sanofi, Eli Lilly; to offer generic diabetes drug at 50pc discount

    Novo Nordisk in race with rivals Sanofi, Eli Lilly; to offer generic diabetes drug at 50pc discount

    Medical Dialogues Bureau8 Sept 2019 9:45 AM IST
    Novo will offer a generic version of its most heavily prescribed insulin drug Novolog, used by about a million U.S. patients, at a 50% discount...
    Boehringer Ingelheim gets USFDA nod for Ofev capsules to treat lung disorder

    Boehringer Ingelheim gets USFDA nod for Ofev capsules to treat lung disorder

    Medical Dialogues Bureau8 Sept 2019 9:30 AM IST
    Ofev capsule is aimed at slowing the rate of decline in pulmonary function in adults with interstitial lung disease associated with systemic...
    Novartis wins USFDA breakthrough tag for Capmatinib to treat lung cancer

    Novartis wins USFDA breakthrough tag for Capmatinib to treat lung cancer

    Medical Dialogues Bureau8 Sept 2019 9:25 AM IST
    Novartis is aiming to win approval for oral capmatinib as a first-line treatment for patients with metastatic MET exon14 skipping-mutated non-small...
    Bristol-Myers blockbuster Opdivo fails to meet goal of brain tumour study

    Bristol-Myers blockbuster Opdivo fails to meet goal of brain tumour study

    Medical Dialogues Bureau8 Sept 2019 9:15 AM IST
    The drug, Opdivo, when used along with the current standard of care for glioblastoma multiforme, did not prevent cancer from spreading when compared...
    Cigna new plan to cover expensive gene therapies including Novartis Zolgensma, Luxturna

    Cigna new plan to cover expensive gene therapies including Novartis Zolgensma, Luxturna

    Medical Dialogues Bureau8 Sept 2019 9:00 AM IST
    The first two gene therapies to be included in Cigna Corp's program are blindness therapy, Luxturna, and the most expensive drug in the world...
    Lupin gets USFDA nod for generic version of Emend Injection to prevent vomiting associated with chemotherapy

    Lupin gets USFDA nod for generic version of Emend Injection to prevent vomiting associated with chemotherapy

    Medical Dialogues Bureau7 Sept 2019 9:45 AM IST
    Fosaprepitant for injection is a generic version of Merck Sharp & Dohme Corp's Emend for injection in the same strength, Lupin said.New Delhi:...
    Cipla, B J Wadia Hospital enter partnership to set up paediatric palliative care unit

    Cipla, B J Wadia Hospital enter partnership to set up paediatric palliative care unit

    Medical Dialogues Bureau7 Sept 2019 9:40 AM IST
    Cipla Foundation strongly believes that palliative care focuses on providing relief from symptoms and stress of illness at any point, yet most...
    PrevNext

    Popular Stories

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok